It's not just marketing.. dose monitoring and treatment efficacy in traditional chemotherapy has been an ongoing problem since the beginning. This is especially problematic when the basis for chemotherapy is, well, killing cells. Current imaging techniques are ill suited for continual monitoring - either because of cost or further radiation damage.
Siemens and Sirtex, page-2
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $65.79M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 15.5¢ | $154.1K | 994.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 270264 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 3106576 | 27 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |